The Traderszone Network

25 October, 2017 by The TZ Newswire Staff Comments Off on Caterpillar Sends Dow Higher but Appears Top Heavy

Caterpillar Sends Dow Higher but Appears Top Heavy

Caterpillar’s third quarter results were better than expected, but the stock has been at oversold levels since mid-September.

25 October, 2017 by The TZ Newswire Staff Comments Off on Should You Buy Skechers After its Post-Earnings Pop?

Should You Buy Skechers After its Post-Earnings Pop?

Shares of Skechers (NYSE: SKX) surged more than 40% after the footwear maker reported its third quarter earnings on Oct. 20. That rally, which propelled the stock to its highest levels in over a year, was surprising since many other footwear makers — like Nike (NYSE: NKE) and Under Armour (NYSE: UAA) (NYSE: UA) — had fallen out of favor.

read more

25 October, 2017 by The TZ Newswire Staff Comments Off on 3 Things to Watch When ExxonMobil, Chevron, and Total SA Report Q3 2017 Earnings

3 Things to Watch When ExxonMobil, Chevron, and Total SA Report Q3 2017 Earnings

It’s going to be a busy day for the oil and gas industry as three of the sector’s biggest companies — ExxonMobil (NYSE: XOM), Chevron (NYSE: CVX), and France’s Total SA (NYSE: TOT) — all report third-quarter 2017 earnings on Friday, Oct. 27. With Halloween just around the corner, investors are hoping for treats and not tricks from these oil majors.

But it can be tricky to keep track of all these giant corporations at once. Here’s one simple thing investors should watch out for in each of these companies’ earnings reports.

read more

25 October, 2017 by The TZ Newswire Staff Comments Off on Why MacroGenics, Inc. Stock Soared Today

Why MacroGenics, Inc. Stock Soared Today

Shares of the clinical-stage oncology and autoimmune disease specialist MacroGenics (NASDAQ: MGNX) ended the day higher by a healthy 17.36% on a whopping 17.5 times the average volume.

The catalyst? Macrogenics’ shares took flight after the company announced a licensing deal with Incyte Corp. (NASDAQ: INCY) for its programmed cell-death protein 1 (PD-1) inhibitor, MGA012, that’s being assessed in four solid tumor types in an early-stage dose-escalation study. 

Image source: Getty Images.

read more

25 October, 2017 by The TZ Newswire Staff Comments Off on Traders in Thailand

Traders in Thailand

Hi!

New to this forum. I have been trading full-time for 20 years in the European markets. But now I am looking at starting trading the stock market in Thailand. Anyone here that is trading the SET? It would be interesting to get more insights about the specifics, from what I have seen so far it seems like there are some potential big hurdles to overcome as a foreign investor.

I am planning to go to Bangkok in December to if possible take a closer look at the market.

25 October, 2017 by The TZ Newswire Staff Comments Off on Aflac Boosts Dividend, Guidance Despite Premium Declines

Aflac Boosts Dividend, Guidance Despite Premium Declines

Insurance is a complex business, and there are many segments of the industry that have relatively little exposure to everyday people. Aflac‘s (NYSE: AFL) supplemental insurance products help flesh out the more basic health and disability insurance coverage that many Americans get through work-based group benefit plans, and Japanese customers also benefit from Aflac’s extensive product lineup across the Pacific.

read more

25 October, 2017 by The TZ Newswire Staff Comments Off on Trump, GOP at odds over using 401(k)s to pay for tax cuts

Trump, GOP at odds over using 401(k)s to pay for tax cuts

Trump, GOP at odds over using 401(k)s to pay for tax cutsPresident Donald Trump and Republicans were at odds on Wednesday over changing the 40

read more